In the study, Fluorescent tagging for environmental surface cleaning surveillance in a veterinary hospital 1, researchers at Ohio State University used a fluorescent dye to tag pre-determined surfaces in a large veterinary teaching hospital.
The dye was invisible to the naked eye, but fluoresced under a blacklight (UV-A source). It could be easily removed by regular cleaning.
Surfaces were tagged and then assessed 24 hours after tag placement to determine whether they had been cleaned. Tagging and assessment took place during non-peak hours in an attempt to eliminate observer bias. The study ran for a period of 5.5 weeks between June and July 2014 and a total of 4984 surfaces were tagged and assessed.
Jason Stull, corresponding author of the paper said: "Overall, 50% of surfaces were adequately cleaned so that the tag was completely removed. Cleaning varied widely by surface/object and hospital location. Of the surfaces designated as having primarily human contact, the equipment cart and door handle to the dog walking area were most frequently cleaned (100%), whilst examination equipment including the otoscope, ophthalmoscope and swivel light handle were the least frequently cleaned (2.3%).
"Of the surfaces designated as having primarily animal contact, the ward cage interior was the most frequently cleaned (89.0%) whilst the dog run interior was the least frequently cleaned (23.1%). In terms of hospital location, the most frequently cleaned area was radiology (77.5%) and the least frequently cleaned area was the small animal treatment area (4.2%)."
The overall proportion of surfaces satisfactorily cleaned was similar to that reported in previous studies, however, the findings for some surfaces and hospital areas differed.2 This demonstrates the importance of veterinary cleaning surveillance in individual practices so that targeted interventions can be implemented.
Nicholas Jeffery, editor of JSAP said: "With health-care associated infections being a persistent problem in human and veterinary medicine, it is important that surfaces and equipment within the veterinary practice are adequately cleaned. This research demonstrates the potential use of a commercial fluorescent dye for veterinary cleaning surveillance to inform hospital cleaning practices."
The full article can be found in the February issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13090
References
The new facilities use teaching aids and models to allow students to refine their practical skills and build confidence before being let loose on real patients.
As part of the official opening, Princess Anne toured the School of Veterinary Medicine, where she met with staff and students and saw a demonstration of a new equine gut model that offers an alternative to using live animals for research into the gut microbiota of horses and how they are affected by diet, disease and medication.
Professor Chris Proudman, Head of the School of Veterinary Medicine, said: "We are honoured to welcome The Princess Royal to the Vet School today, and very grateful that Her Royal Highness has officially opened the Large Animal Clinical Skills Facilities. Preparing students for life as a vet is our number one priority; the hands-on experience they will get through the use of this facility is invaluable and enables them to give the best possible care to all animals.
"We are also very grateful to the Longhurst family, without whom these teaching resources would not have been possible – their generosity is helping us to teach the vets of the future."
Licensed for use from 6 weeks of age - and in pregnant and lactating bitches and queens - Evicto provides adulticidal, larvicidal and ovicidal flea protection, which can also help to control environmental flea infestations in areas where the pet has access. It also treats ear mites, biting lice, intestinal roundworms, sarcoptic mange in dogs, intestinal hookworms in cats and can be used to prevent heartworm disease with monthly administration.
Evicto is presented in packs of 4 pipettes which are transparent so owners can see that the full dose has been applied. The company also highlights that with Evicto pets can be bathed 2 hours after treatment without loss of efficacy.
Claire Lewis, Product Manager at Virbac said: "We are pleased to add Evicto to our award-winning range of parasite protection products.
"Evicto can also be used concurrently with Milpro, making it the perfect product partnership."
Evicto is available from the veterinary wholesalers now.
For information, speak to your Virbac Territory Manager.
The campaign will highlight things that can be done to help anxious pets, including getting professional advice from a behaviourist or trainer and using the company's products.
There's a marketing pack for practices, to help you educate owners and promote the month. It includes bunting, wall displays, posters, leaflets and gift vouchers for pet owners.
To raise awareness, Ceva will also be running a PR and advertising campaign together with a social media initiative in which owners will be encouraged to share their experience of having an anxious pet on Instagram and Facebook.
Abigail King, senior product manager at Ceva said: "It is widely known that humans suffer from anxieties, but pets do too with 82% of dogs and 89% of cats reported to be scared of something1.
"It is therefore important that we educate pet owners on the signs of stress and the help and support that they can give to their pets.
"Pet Anxiety Month will get people talking and we want people to know that there are products out there to support pets and that help is at hand to get the right advice, which is extremely important."
For further information, visit the Pet Anxiety Month website or follow the campaign on Instagram and Facebook. To request the Pet Anxiety Month marketing pack, email cevauk@ceva.com.
Reference
MSD says Lawsonia intracellularis is found on many finishing farms throughout the UK, and can affect weight gains, feed conversion ratios (FCR) and lead to increased mortality.
The new vaccine means that if piglets are vaccinated at three weeks, they will be protected against the bacteria from seven weeks.
Rubén Del Pozo Sacristán, technical manager for pigs at MSD Animal Health, said "Lawsonia intracellularis is present on most UK farms and can hamper a farm’s true potential as it spreads rapidly in faeces and on people or rodents, but symptoms can be hard to identify, as they’re often similar to many other diseases.
"Acute forms are often noticeable with symptoms such as diarrhoea or an increase in mortality, but the subclinical form, which is most common, can be hard to identify. Diarrhoea is not always present and often indicators are an increase in FCR and a reduction in weight gain leading to variation in pig performance, but this is similar to many other health issues.
"Administering an intramuscular vaccination will ensure every animal receives the correct dose, compared to other administrative routes. Porcilis Lawsonia can help reduce the clinical signs, production losses and mortality caused by Ileitis."
For more information on Porcilis Lawsonia, refer to the SPC sheet.
Designed to help veterinary practices save clients' time and improve compliance, VetsDeliver supplies Bravecto - the company's 12 week flea and tick treatment - with the wormer of the vet's choice, by post.
Before the pandemic, practices registered clients for the service online or during an appointment and clients would have to collect the first treatments from the practice.
In response to the pandemic, however, MSD has made now it possible for clients to register from home and get their first treatments sent by post.
Amanda Melvin, Marketing Manager for Companion Animals at MSD Animal Health said: "We are all in unchartered territory and we appreciate the pressure veterinary teams are under to continue to care for their clients and local pet community.
"Many businesses are having to add new services to support online facilities and home delivery, and for vets there is also now a need to reduce footfall into practice while still generating income. Making sure effective parasite control is available will help improve compliance as temperatures rise and the risks to the health of our pets increase. It's one less thing for you and your clients to worry about."
For further information, contact your MSD Animal Health account manager or go to www.msd-animal-health-hub.co.uk/vetsdeliver.
In next year's election, there are three places on Council for elected veterinary surgeons, with successful candidates serving four-year terms.
The nomination period runs until 5pm on Friday 31 January 2020. In order to stand, candidates need to complete a nomination form, submit a short biography and personal statement and supply a high resolution digital photo.
Each candidate also needs to have two nominators who need to be veterinary surgeons who are on the RCVS Register but are not current RCVS Council members.
Eleanor Ferguson, RCVS Registrar and Returning Officer said: "As always, we would encourage those who are interested in having their say in some of the key debates in the regulatory sphere, such as our under care review, our policies around the impact of Brexit and our vision for new veterinary legislation, to become a candidate.
"RCVS Council is at its best when it encompasses a broad range of perspectives, experiences and knowledge, and so we encourage people from all areas of veterinary life and all levels of experience to put themselves forward and share their expertise and insight."
Nomination forms, guidance notes and frequently asked questions for prospective RCVS Council candidates can be found at www.rcvs.org.uk/rcvscouncil20.
Prospective candidates for RCVS Council are welcome to contact the Registrar, Eleanor Ferguson (e.ferguson@rcvs.org.uk) and the RCVS CEO, Lizzie Lockett (l.lockett@rcvs.org.uk) for more information about the role of the College and/or RCVS Council.
RCVS Council will also be holding its next public meeting on Thursday 23 January 2020, prior to the closure date for Council candidate nominations. Prospective candidates are welcome to attend the Council meeting as an observer. Contact Dawn Wiggins, RCVS Council Secretary, on d.wiggins@rcvs.org.uk if you wish to attend.
The new editorial team of Ed Hall, David Williams and Aarti Kathrani says the manual has been completely rewritten and reorganised to provide a current, well-structured overview of the main gastrointestinal diseases that challenge both clinical practitioners and academics.
The Manual is divided into four sections:
Diagnostic procedures and techniques: history taking, physical examination, clinical pathology, imaging and biopsy.
Diagnostic approaches to problems: diagnostic approach to complaints/problems affecting the GI tract, pancreas and liver.
Patient management: treatments available for GI, pancreatic and liver disease, including a chapter on fluid and nutritional therapy.
Diseases of specific systems/organs: conditions of organs of the GI tract, including pathophysiology, clinical signs, diagnosis, treatment and prognosis.
Ed Hall said: "The busy small animal practitioner is likely to see a dog or cat with GI signs most days and having this Manual as a resource should give them greater insight into the conditions they are treating and hopefully make their job more satisfying."
The BSAVA Manual of Canine and Feline Gastroenterology is available in a printed edition (£90; £60 to BSAVA members) and an online edition (£75 +VAT; £50 +VAT to BSAVA members).
Inigo’s abstract entitled “Predictive value of cardiac remodelling on survival in dogs with persistent atrial standstill – the UK perspective” sought to determine the survival of dogs in the United Kingdom with persistent atrial standstill (PAS) after pacemaker implantation and the prognostic value of cardiac remodelling. The Congress Programme Committee were impressed by Inigo’s innovative presentation, praising the planning and execution of the multi-centre project.
Ditte’s presentation was entitled “Evaluation of a point-of-care dot Enzyme-Linked Immunosorbent Assay to detect antibodies against canine parvovirus, distemper virus and adenovirus before revaccination”.
Her study described the findings of a prospective non-inferiority study of a point-of-care semi-quantitative titer test performed on canine serum samples and compared to gold standard analysis. Sensitivity, specificity, positive and negative predictive values of the point-of-care titer test were determined for the gold standard titer cut-offs for canine adenovirus, canine distemper virus and canine parvovirus. Ditte was commended by the Congress Programme Committee for the quality of presentation as well as the practical and clinically applicable findings of the study.
The BSAVA Congress Clinical Abstracts, including the winners’ abstracts, are now available to view in the BSAVA Library here: https://www.bsavalibrary.com/content/book/10.22233/9781913859039.
The new Mind Matters Initiative (MMI) Kite App is the result of a collaboration with The Kite Programme. It offers a series of bespoke microlearning modules - known as 'kites' - about mental health and wellbeing.
Microlearning is a type of learning which delivers content in bite-size modules. It usually combines a mixture of interactive activities, images and videos, which can be worked through in as little as five minutes.
The first ‘Kites’ available on the app will cover subjects like breathing activities, mindfulness, time management and physical activity for mental health.
New modules will be added over the weeks and months ahead, in response to feedback from users.
Angharad Belcher, RCVS Director for Advancement of the Professions, said: “Veterinary professionals undertake vital work for animal health and welfare, but the intensity and pressure of their work can take its toll on mental health and wellbeing. Sadly, research shows that compared to the general population, veterinary professionals are more likely to experience mental health distress, including depression and anxiety.
“We recognise how hard it can be for veterinary professionals to fit wellbeing activities into their busy workdays and understand that everyone’s mental health needs are different. By collaborating with The Kite Program, we wanted to create a wellbeing platform that was accessible, flexible and had a range of activities to meet a variety of mental health and wellbeing needs. This app will be another useful tool for the professions, and we are pleased to be able to offer it free of charge.
“We are really looking forward to hearing feedback from the professions about the platform and creating more modules based on their wants and needs.”
The College highlights that users cannot input any personal information into the app and the only data it will hold is a record of active users.
To register for the app, visit: https://www.vetmindmatters.org/mmi-app.
The app will also be demoed at BEVA Congress 2021 (5th-7th September, Birmingham ICC).
The recall was initiated because a visual inspection confirmed the possibility of particulate contamination which is not acceptable for an intravenous use preparation.
The recall is for the following batches only:
108AB Expiry 12/01/2023113H Expiry 16/03/2023
Ceva Animal Health Ltd is contacting veterinary surgeons, retailers and wholesale dealers to examine inventory and quarantine products subject to the recall.
For further information, contact Peter Kyte Business Unit Manager on +44 1494 781510.
The study, titled “Development and progression of proteinuria in dogs treated with masitinib for neoplasia: 28 cases (2010 – 2019)”, also suggests that a urine protein: creatinine greater than 0.5 should prompt reassessment within one week.
For the study, the clinical records of 38 dogs referred to a single university teaching hospital between 2010 and 2019 for treatment of neoplasia with masitinib were retrospectively evaluated.
Data was collected at masitinib initiation and at various timepoints following the start of treatment.
Data gathered included the masitinib dose given and any changes to medication administration or dosing since the previous visit, presence of gross disease and the results of haematology and biochemistry profiles, urinalysis and urine cultures.
Urinalysis results were only included if they were performed at a reference laboratory.
At each timepoint, the urine was classified as non-proteinuric (UP:C ≤0.5) or proteinurinc (UP:C >0.5). Proteinuria was then categorised as likely pre-renal, post-renal, physiological renal or pathological renal.
Dogs were grouped based on the presence or absence of proteinuria at baseline. Non-proteinuric dogs were further divided, based on whether proteinuria developed following treatment during the study.
Of the 28 dogs in the study, five were being treated for epitheliotropic lymphoma, one for vulval lymphoma, one for malignant melanoma and 21 for mast cell tumours.
Twenty-two (79%) dogs were non-proteinuric and six were proteinuric at baseline.
Of the dogs that were non-proteinuric at baseline, four (18.2%) developed proteinuria within one month of treatment initiation. Median time to first detection of proteinuria was 14.5 days (range: 13 to 31).
Of the dogs with pre-treatment proteinuria (n=6), masitinib treatment was discontinued due to lack of efficacy in three dogs, and three were euthanased during treatment, two for disease progression and one for an unknown reason.
Dr Margaux Kuijlaars, corresponding author for the paper, said: “Patients developing proteinuria should be investigated to exclude non-renal causes. This should allow for more informed recommendations on the monitoring and management of proteinuria and further masitinib treatment in these patients to be made. Masitinib treatment can be considered in patients with pre-treatment proteinuria and does not inevitably cause worsening of proteinuria.
“The findings of this study add to the evidence base for the use of masitinib in treating neoplasia in small animal patients. The use of masitinib in dogs in this study was off-licence as C-KIT MCT expression was not determined, and many dogs were treated for other tumours.”
Nicola Di Girolamo, Editor of JSAP, said: “Little is known about which dogs are predisposed to becoming proteinuric following treatment with masitinib for neoplasia. Due to the small number of dogs in this study that developed proteinuria, conclusions about predisposing factors cannot be definitely drawn.
"The findings of this study add to the evidence base and demonstrate the need for larger, prospective trials including a control population and longer period of follow-up.”
The full article can be found in the August issue of the Journal of Small Animal Practice and can be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13305. It is open access and can be freely accessed by anyone.
Tim was the principal veterinary surgeon at Nine Mile Veterinary Group in Wokingham, Berkshire, from its opening in 1985. He grew the business from one vet and three staff to 16 vets and 60 staff, before selling to CVS in 2007.
Thereupon he became the National Veterinary Director for CVS, supporting the business as it grew from 200 to 1200 vets and supporting individual vets and practices with management advice and clinical practice.
In more recent times Tim has been working with a peripatetic surgery group.
Tim has worked at Guide Dogs before: between 1987 and 2007, he was a Centre Veterinary Advisor at the charity’s now-closed site in Wokingham.
Tim said: “Guide dogs are fantastic to work with – they are good-natured and easy to handle, and the owners always have the best interests of the dog at heart. Plus, you know you are helping more than someone’s pet, a working dog making a real difference to a person’s life. A guide dog needs to be happy and healthy to fulfil its role. It all adds up to a very different flavour of vet work.
“I am looking forward to being back, but in a more central role with more strategic responsibility. The veterinary world has changed so much, even in the last ten years, and it will be good to draw on my experiences to help Guide Dogs traverse that change.
“It’s important that we keep the healthcare of guide dogs at the top of the priorities list; the dogs have always been at the very core of the charity. It’s crucial that we have solid relationships with veterinary practices, to ensure our dogs receive the greatest care at the best value to the charity."
The company initiated the recall after identifying a potential for the sterility/stability of the product to be compromised due to a crimping problem of the aluminium cap.
The recall is for the 100 ml bottles of the following batch only:
Batch No.0C3829 Expiry Date 03/12/2022
Vetoquinol UK Ltd is contacting veterinary surgeons and veterinary wholesalers to examine inventory immediately and quarantine products subject to this recall.
For further information, contact the Customer Services Department on +44 1280 814500 Option 1 or email: UK_office@vetoquinol.com.
The report also revealed the devastating impact on overworked veterinary staff, with some left in tears by abusive owners venting their frustration at being unable to find care for their animal.
Anecdotally, the problems highlighted by ITV News are being seen elsewhere in the country, with more and more vets now starting to question whether or not the current requirement to provide out of hours care is sustainable in a world where there are more clients who increasingly expect flea treatment advice and other non emergency situations to be dealt with at 3:00am in the morning.
Various solutions have been proposed in a forum discussion on VetSurgeon.org, including the removal of the requirement to provide an OOH service, for the RCVS to give vets the confidence to say no to non emergencies, a change to the CoPC to require vets to provide emergency care within 24 hours, not 24 hours a day, a requirement for new grads to undertake OOH as part of their PDP, and/or a requirement for OOH centres to have 3 vets on duty at any one time (which could improve working conditions).
As the ITV report pointed out, the fundamental issue is one of a shortage of supply over demand, for which there is no overnight fix. However, many feel that reducing the demands of providing OOH could ease the situation considerably.
IVC says the new brand will allow better communication for equine teams within the IVC Evidensia group as well as collaboration with the wider equine world.
IVC Evidensia Equine Vets range from graduates to European Specialists, working in both dedicated equine and mixed practice, with all practices supported by the four large equine veterinary referral hospitals in the UK: Donnington Grove Veterinary Group, Fyrnwy Equine Group, Oakham Veterinary Hospital and Pool House Equine.
IVC says the brand's mission is to put the welfare of horses at the heart of everything it does, to providing outstanding continuity of care for all equine species and breeds across the network, to be at the forefront of continual professional development, supporting and facilitating the development of clinical and leadership skills across all their equine teams, and to build the leading network for equine veterinary care across Europe.
Richard Stephenson, Chair of the IVC Evidensia Equine Clinical Board, said: "Our network brings together all forms of equine work from ambulatory practice to some of leading UK equine referral centres.
“It gives support to all our staff in their careers. We facilitate clinical development from the graduate academy, through intern training, residencies and training up to European Diplomat level.
“We provide coaching and leadership, flexible roles and friendly, inclusive teams.”
For more information, visit https://www.ivcevidensia.co.uk/Equine or stand B01 at BEVA 2021 congress.
The event, which is open to 2019 and 2020 graduates, offers a day to catch up with classmates, network and create new connections, whilst accumulating six hours of CPD.
During the day, delegates will be able to practise their skills with real-life actors who play the part of clients, recreating difficult situations they may be facing in practice, which will then be dissected by the audience.
You will also be able to talk to the heads of the main veterinary organisations and get advice from representatives of the BVA, RCVS, VMG, BSAVA, SPVS and SPVS Educational Trust.
Ticket holders will also have access to a digital delegate bag with exclusive content from VDS Training, Supporters & Sponsors.
Tickets are £35 and can be bought at: https://www.bit.ly/VDSGraduateSupportDay2021 or for further information, contact info@vds-training.co.uk
The objectives of the study1 were to assess the impact of the pandemic on the management of laminitis susceptible horses and ponies, to identify challenges faced in implementing COVID-19 based guidance, and to ascertain areas of decision making and policy development which could undergo improvement in future pandemic or emergency scenarios.
Lead author Ashely Ward, a PhD student at SRUC said: "We discovered that lockdown-associated factors had the potential to compromise the welfare of horses and ponies at risk of obesity and laminitis.
“These included: disparate information and guidance, difficulties enacting public health measures in yard environments, and horses having reduced exercise during the pandemic.
"Our conclusion was that guidelines should be developed for the care of horses and ponies at risk through collaborative input from veterinary and welfare experts. This would help to reduce the negative impacts of future lockdown events in the UK.”
Clare Barfoot RNutr, Marketing and Research and Development Director at Spillers said: “This work carries important recommendations to reduce equine welfare risks during any future lockdowns.
“This summer our primary focus has been on helping horse owners keep their horses at a healthy weight to reduce the risks associated with obesity, in particular laminitis. Until formal guidelines are developed we hope our range of practical advice, available online and via our Care-Line will help, should there be another lockdown."
The study was conducted in tandem with research looking at how the challenges brought about by the Covid-19 lockdown affected horse on the human/animal interaction. The conclusion, disseminated by SRUC last week, concluded that the coronavirus pandemic had a negative impact on the mental health and wellbeing of horse owners. https://www.sruc.ac.uk/all-news/horse-power-helps-owners-through-lockdown
With the profession currently suffering a staffing crisis, some now question the ability of the profession to provide a blanket OOH service, and whether it should remain a requirement for all practices.
A logical first step, however, might be to discover just what percentage of OOH calls really are genuine emergencies, and how many are simply the result of society's increasing demands for a 24 hour service, not just from the veterinary profession. Hence the survey.
The question is open to veterinary surgeons and nurses working in general practice only.
https://survey.alchemer.com/s3/6495987/Out-Of-Hours
Harrison Family Vets opened its first practice earlier this month in Woodley, Reading, in a £350,000 investment that created eight jobs.
The plan is for the next practice to open later this summer in the Midlands, before the group expands north towards the end of the year. The group is now searching for further properties across the north and south of England, with plans to open 75 practices by the end of the decade.
Tim joined his dad's practice in 1995 as General Manager. He later co-founded Vets4Pets in 2001 before joining Mars Inc. to head the overseas growth of Banfield, then the world’s largest veterinary practice. He then rejoined the family business to grow it further, until it was acquired by IVC Evidensia in 2018.
Alongside Tim is operations director, Kristie Faulkner who also worked at White Cross Vets until it was acquired by IVC, whereupon she became regional operations manager, overseeing more than 200 of the IVC's practices across the South East of England.
Between 2012 and 2018, White Cross Vets was repeatedly named as one of the UK’s best employers and a truly extraordinary place to work. The company secured a place in the prestigious ‘Top 100 Sunday Times Best Small Companies to Work For’ league table for seven consecutive years, as well as being the inaugural SPVS Wellbeing Award Winners.
Tim said: “The whole ethos at Harrison Family Vets is about fostering a culture within our team that sets us apart and differentiates our practice from all others. Every individual’s strengths and personality traits will contribute to what we do, in a family-orientated environment. Our culture is about looking after people. Focus on attracting the very best people and then look after them as much as possible. A successful practice with a fabulous reputation amongst the profession and amongst clients is what automatically follows.
“Our state-of-the-art clinics boast extensive facilities including on-site laboratories, full x-ray suites, operating theatres, ultrasonography and separate dog and cat wards that have been carefully designed with mood lighting, aromas and music to offer a calming atmosphere.
We’ve also worked hard to create a customer experience that’s more akin to an Apple store, than a traditional veterinary practice. We don’t have a reception desk and instead, our front of house team have the autonomy to freely interact with our clients and their pets.
Our waiting areas feature bespoke pods, which give clients their own space and offer pets privacy, thus shielding them from the stresses of facing other pets in a traditional waiting room. Each pod also has its own tablet where clients can update their details, sign up to our Total Wellness Plan or even order fresh and healthy dog food from Butternut Box.
“Everyone wants to know why we want to start another veterinary group now. For Kristie and I the timing is perfect as there is a clear void to fill. The people-focused independent practice is becoming a thing of the past and is what the profession is yearning for. This will attract the very best team members which in turn will provide a superior client and pet experience.
"Creating a successful business and building a fantastic team is incredibly exciting and we genuinely believe Harrison Family Vets can become the most innovative, forward-looking and caring practice, as well as the employer of choice for vets and nurses, in the UK.”
VetSurgeon.org wishes Tim and Kristie all the very best luck in the world with their new venture, although one suspects that they won't need to rely on luck. White Cross under his direction was consistently doing extraordinary things to foster what seemed to be a remarkably good working environment. If they can come close to repeating the formula, or improving on it, they must be on to a winner.
In the 15 minute podcast, Carolyn Kyte, a vet in general practice, talks to Natalie Barnard, a veterinary dermatology specialist from Highcroft Referrals, and together they share their experience of the challenges of treating animals with otitis and explain why owners play a important role in successful treatment of the condition.
Dechra Brand Manager Carol Morgan said: “Otitis is very common, particularly in dogs, but there is no ‘quick fix’ when some underlying factors are causing the problem. This can lead to frustration for the pet’s owners and animals not getting the consistent treatment they need to get better.
“What Carolyn and Natalie bring to the table with their new podcast for the Dechra Academy is a light and insightful discussion about communication and education being the keystone for better otitis outcomes and how vets can improve on their consultation skills to handle cases better.”
The otitis podcast is here: https://academy.dechra.com/learn/course/internal/view/elearning/1034/think-differently-about-otitis
The company has set up the Group Veterinary Medical Board (GVMB) Research Fund to offer practical support and financial assistance.
Deputy Chief Medical Officer Alistair Cliff (pictured right), said: "We introduced funding for research across our European Group at the beginning of this year and have been overwhelmed by the interest this has received. We understand the importance of these opportunities for professional development and also an individual’s job satisfaction.
“We believe it is incumbent upon us to increase this support for research to contribute to the advancement of knowledge, the development of our teams and our value as an employer. Ensuring our teams are content, with a diverse range of ways to develop, is important in allowing us to continue to attract the best people in the profession.
The GVMB Research Fund made its first awards in June 2021. Seven grants were provided to research teams from three countries – the UK, The Netherlands and France. In total, the funding will benefit some 21 researchers working as interns, residents, referral clinicians and specialists from a variety of different settings.
Chief Medical Officer Amanda Boag said: "It is incredibly satisfying to be able to provide support to our teams at critical points of their professional development. In some cases, funding has been provided to experienced researchers looking to contribute yet more to the understanding within their respective disciplines. In other examples, we have supported interns, who are at the very beginning of that journey and at a stage where funding can be difficult to secure.”
She added: “With additional interest from several general practitioners and nurses, the fund has quickly become a significant benefit to working for IVC Evidensia."
The GVMB also provides resources to guide teams on study design, ethical requirements, and statistical support. Less experienced researchers can access a network of Research Partners - a group of experienced clinicians from around Europe who have volunteered their own time to mentor colleagues through a collaborative approach to a project.
The company says that with an estimated 3.2 million UK households welcoming a new pet into their family home during lockdown1, many experienced and new dog owners will be unaware of the risks to their dog of CCC when it socialises, hence the new risk assessment tool, which is available at: https://www.msd-animal-health-hub.co.uk/KBPH/contagious-canine-cough-risk-assessment.
The risk assessment campaign will be supported with 'Does your dog ...' posters for vets, information and advice for dog owners on the website and a social media campaign encouraging dog owners to spread the information to other dog owners.
Carley Chutter, Nobivac(r) Product Manager at MSD Animal Health said: "With so many new dog owners now socialising more, taking their dogs on holiday and even considering taking their dogs into the office, protecting their dogs as they socialise is vital.
"Currently only an estimated 1 in 3 vaccinated dogs in the UK are also covered against Bordetella2 so the 'Ask us to protect your dog' resources offers the chance for practices to start the conversation about protection with clients.
"A common barrier to vaccinating against CCC is the belief that it is only necessary for dogs going into kennels, rather than all social dogs. Most dogs meet others, however, while out walking, during training, or while attending the vets, CCC is infectious even at low levels. Indeed, dogs can be asymptomatic but infectious.
"So, improving protection levels against this disease which is distressing for both the owner and dog, is important in both reducing the risk of outbreaks and the need for antibiotic treatment."
Nobivac(r) Respira Bb injectable vaccine against Bordetella bronchiseptica, gives 12 months protection when used as a single-dose booster in dogs previously vaccinated with Nobivac(r) KC. Dogs not previously vaccinated against Bordetella bronchiseptica require two doses administered four weeks apart. Duration of immunity is 7 months after the primary course and 12 months after a booster with Nobivac(r) Respira Bb. It may also be given 12 months after a primary course in cases where the 7 months dose is missed.
To support the use of Nobivac(r) Respira Bb a range of tools are available to practices and further information can be found at www.nobivacrespiraBb.co.uk, or contact your MSD Animal Health account manager.
The three companies will now offer their services, which include marketing strategy, brand management, search engine marketing, online advertising, email marketing, webchat, social media copywriting, graphic design and web design under the VetsDigital brand.
Sarah Spinks, Managing Director of VetsDigital, said: "In the pursuit of better animal welfare, we empower animal owners, and bridge the gap between the veterinary professional and the pet parent using the most effective digital channels.
“As one combined company, we become Europe’s leading digital agency that specialises in the veterinary sector. With our current presence in 11 countries, we’ll be able to further develop our network whilst still providing our clients with the same personal service they’ve come to expect and deserve.”
Marcelo Alves, Managing Director of Vet Inflow, will move into the role of Managing Partner for Portugal and Spain at VetsDigital, as the company expands to have bases in both the UK and Portugal.
Will Stirling, who becomes a Managing Partner at VetsDigital, bringing with him 14 years of experience marketing in the veterinary industry, having previously worked with veterinary group YourVets and CVS, said: "The veterinary industry is buzzing with growth and renewal as many parts of veterinary marketing and management move into the digital realm. It’s the perfect time to combine the talents of our 3 teams, so that together we can offer industry-leading digital marketing services to veterinary businesses across the UK and Europe.
For more information, visit: https://vetsdigital.com
The Canine Cruciate Registry is a free, anonymised, data collection audit tool that will enable veterinary surgeons to share information on techniques and procedures to improve patient care.
RCVS Knowledge will collect data from both vets and dog owners on patients recovering from cruciate surgery to identify which procedures and techniques give the best outcomes and have the fewest complications.
According to the charity, injury to the cruciate ligament is one of the most common causes of lameness and the most common type of orthopaedic problem in dogs, affecting about 1 in every 200 individuals in the UK each year.
Surgery is widely accepted to result in better outcomes for cruciate patients, however, there is a lack of high-quality evidence comparing which surgical techniques and implants are most effective and have the fewest complications. The Canine Cruciate Registry aims to fill this gap and provide evidence that veterinary surgeons worldwide can access to help guide decision-making about techniques for every patient they see with a cruciate rupture.
RCVS Knowledge has developed the registry with Amplitude Clinical Outcomes, a global leader in online registry software. It involves a web-based series of questions that vets, and dog owners are asked to complete throughout the dog’s care, to monitor their long-term progress.
In human medicine and surgery, outcome measures are common practice, with many human surgeries involving mandatory data entry onto a national registry.
Clinical Lead for the RCVS Knowledge Canine Cruciate Registry is veterinary orthopaedic surgeon Mark Morton. He said: “Thanks to several years of hard work and development from a group of vets across the UK and the team at RCVS Knowledge, I am delighted that the Canine Cruciate Registry is now up and running.
“We want to work with as many vets and dog owners as possible, we want to know about complications, we want to know about different techniques and how dogs recover so we can build a knowledge base for vets around the world to improve the quality of care they provide.
“As vets, it's our job to advise owners on treatments options, as well as what can go wrong with those treatment options and how often these potential complications may occur.
“I invite all vets in the UK as well as owners caring for dogs having cruciate surgery to join us and help improve outcomes for all patients in the future.”
Chair of the RCVS Knowledge Board of Trustees, Amanda Boag said: “This is a hugely exciting step forward in developing quality improvement initiatives within the veterinary profession and potentially transformational in terms of consistency and quality of care for our patients.
“I applaud the vision of the surgeons in setting this registry up and am keen to see how the same approach can be applied in other common disease conditions.”
Orthopaedic Surgeon, Richard Whitelock said: “The benefits of the Canine Cruciate Registry are immense – for dogs, owners and veterinary surgeons. Owners will be able to make better-informed decisions and their feedback on outcomes will be included. Surgeons will be able to monitor and compare their results, adapting and improving their treatments accordingly.
“I believe that the Canine Cruciate Registry could trigger a widespread change in the veterinary profession, we look forward to owners and surgeons across the UK engaging with it.”
The Canine Cruciate Registry has been endorsed by the British Veterinary Orthopaedic Association (BVOA), and all UK vets performing cruciate surgery are encouraged to sign up to the registry.
For more information, visit: www.caninecruciateregistry.org